Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:10 am Purchase |
2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Rock Springs Capital Management LP | 4,973,649 5.720% |
561,666 (+12.73%) |
Filing History |
| 2024-11-22 4:00 pm Purchase |
2024-11-18 | 13G | Aclaris Therapeutics, Inc. ACRS |
Rock Springs Capital Management LP | 6,761,861 6.320% |
3,763,366 (+125.51%) |
Filing History |
| 2024-11-12 4:50 pm Unchanged |
2024-09-30 | 13G | Xilio Therapeutics, Inc. XLO |
Rock Springs Capital Management LP | 3,003,259 6.830% |
0 (Unchanged) |
Filing History |
| 2024-11-12 4:49 pm Purchase |
2024-09-30 | 13G | Mereo BioPharma Group plc MREO |
Rock Springs Capital Management LP | 47,670,850 6.200% |
7,751,595 (+19.42%) |
Filing History |
| 2024-11-12 4:47 pm Sale |
2024-09-30 | 13G | Immunocore Holdings plc IMCR |
Rock Springs Capital Management LP | 0 0.000% |
-2,661,507 (Position Closed) |
Filing History |
| 2024-05-01 4:11 pm Purchase |
2024-04-25 | 13G | Travere Therapeutics, Inc. TVTX |
Rock Springs Capital Management LP | 4,411,983 5.790% |
4,411,983 (New Position) |
Filing History |
| 2024-04-05 2:51 pm Purchase |
2024-03-27 | 13G | Xilio Therapeutics, Inc. XLO |
Rock Springs Capital Management LP | 3,003,259 8.710% |
1,562,500 (+108.45%) |
Filing History |
| 2024-02-14 2:12 pm Purchase |
2023-12-31 | 13G | Xilio Therapeutics, Inc. XLO |
Rock Springs Capital Management LP | 1,440,759 5.230% |
1,440,759 (New Position) |
Filing History |
| 2024-02-14 2:12 pm Sale |
2023-12-31 | 13G | Tempest Therapeutics, Inc. TPST |
Rock Springs Capital Management LP | 0 0.000% |
-823,654 (Position Closed) |
Filing History |
| 2024-02-14 2:11 pm Purchase |
2023-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Rock Springs Capital Management LP | 2,609,125 6.410% |
986,436 (+60.79%) |
Filing History |
| 2024-02-14 2:11 pm Unchanged |
2023-12-31 | 13G | Mereo BioPharma Group plc MREO |
Rock Springs Capital Management LP | 39,919,255 5.690% |
0 (Unchanged) |
Filing History |
| 2024-02-14 2:10 pm Purchase |
2023-07-03 | 13G | Mereo BioPharma Group plc MREO |
Rock Springs Capital Management LP | 39,919,255 6.380% |
8,694,770 (+27.85%) |
Filing History |
| 2024-02-14 2:10 pm Purchase |
2023-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Rock Springs Capital Management LP | 3,681,174 5.960% |
595,147 (+19.29%) |
Filing History |
| 2024-02-14 2:09 pm Sale |
2023-12-31 | 13G | Immunocore Holdings plc IMCR |
Rock Springs Capital Management LP | 2,661,507 5.380% |
-659,559 (-19.86%) |
Filing History |
| 2024-02-14 2:08 pm Unchanged |
2023-12-31 | 13G | GAMIDA CELL LTD GMDAQ |
Rock Springs Capital Management LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 2:07 pm Unchanged |
2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE |
Rock Springs Capital Management LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 2:06 pm Sale |
2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Rock Springs Capital Management LP | 2,152,173 3.850% |
-844,419 (-28.18%) |
Filing History |
| 2024-02-14 2:06 pm Sale |
2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
Rock Springs Capital Management LP | 2,998,495 4.230% |
-962,754 (-24.30%) |
Filing History |
| 2023-02-14 3:01 pm Sale |
2022-12-31 | 13G | Sierra Oncology, Inc. SRRA |
Rock Springs Capital Management LP | 0 0.000% |
-1,184,793 (Position Closed) |
Filing History |
| 2023-02-14 3:01 pm Sale |
2022-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
Rock Springs Capital Management LP | 0 0.000% |
-2,581,299 (Position Closed) |
Filing History |